Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CART-20 in Chemotherapy Resistant or Refractory CD20+ Leukemia and Lymphoma
NCT01735604Phase 2Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2013
- Primary completion
- May 2017
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CD20 CAR T cells in B-cell leukemia (BCL), B cell lymphoma, sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
CD20 CAR T cells
03
Conditions
B-cell leukemia (BCL)B cell lymphoma
Beyond the preview
Go deeper on NCT01735604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01735604.